The DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.
Rare Earth Nanoprobes for Targeted Delineation of Triple Negative Breast Cancer and Enhancement of Radioimmunotherapy
Open accessAbstract
Radiotherapy demonstrates a synergistic effect with immunotherapy by inducing a transformation of “immune cold” tumors into “immune hot” tumors in triple negative breast cancer (TNBC). Nevertheless, the effectiveness of immunotherapy is constrained by low expression of tumor‐exposed antigens, inadequate inflammation, and insufficient tumor infiltrating lymphocyte (TILs). To address this predicament, novel lutecium‐based rare earth nanoparticles (RENPs) are synthesized with the aim of amplifying radiation effect and tumor immune response. The nanoprobe is characterized by neodymium‐based down‐conversion fluorescence, demonstrating robust photostability, biocompatibility, and targetability. The conjugation of RENPs with a CXCR4 targeted drug enables precise delineation of breast tumors using a near‐infrared imaging system and improves radiation efficacy via lutetium‐based radio‐sensitizer in vivo. Furthermore, the study shows a notable enhancement of immune response through the induction of immunogenic cell death and recruitment of TILs, resulting in the inhibition of tumor progression both in vitro and in vivo models following the administration of nanoparticles. Hence, the novel multifunctional nanoprobes incorporating various lanthanide elements offer the potential for imaging‐guided tumor delineation, radio‐sensitization, and immune activation post‐radiation, thus presenting an efficient radio‐immunotherapeutic approach for TNBC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Immune-related effects, including cGAS–STING activation and increased immune cell infiltration, have also been described following nanoparticle-assisted irradiation [18,23,26,91].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition to enhanced radiotherapeutic efficacy, several studies demonstrated durable tumor growth inhibition, suppression of metastatic progression, prolonged survival, and evidence of systemic antitumor immunity [23,26,39,45].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, the most pronounced therapeutic responses were generally observed in multifunctional systems capable of engaging multiple mechanisms simultaneously, particularly combinations of oxidative stress amplification, microenvironment modulation, and immune activation [17,21,26,39,45,52].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Immune-related effects, including immunogenic cell death, dendritic cell activation, macrophage polarization, and cGAS–STING signaling, were also described in selected studies [23,26,91].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with these vulnerabilities, many of the more advanced nanoplatforms identified in this review—including systems targeting sustained ROS amplification, redox disruption, ferroptosis-associated pathways, and immune activation—were preferentially evaluated in TNBC models [23,26,90].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [26]
Experimental — accuracy not yet measured
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The future of immune checkpoint therapy
Sharma, P., & Allison, J. P. (2015) · Science · doi:10.1126/science.aaa8172 · Cited by 4,878
Near-infrared fluorophores for biomedical imaging
Hong, G., Antaris, A. L., & Dai, H. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-016-0010 · Cited by 2,985
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Twyman-Saint Victor, C., Rech, A. J., Maity, A., Rengan, R., Pauken, K. E., Stelekati, E., Benci, J. L., Xu, B., Dada, H., Odorizzi, P. M., et al. (2015) · Nature · doi:10.1038/nature14292 · Cited by 2,434
ROS and the DNA damage response in cancer
Srinivas, U. S., Tan, B. W. Q., Vellayappan, B. A., & Jeyasekharan, A. D. (2019) · Redox Biology · doi:10.1016/j.redox.2018.101084 · Cited by 2,144
Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
Deng, L., Liang, H., Burnette, B., Beckett, M., Darga, T., Weichselbaum, R. R., & Fu, Y.-X. (2014) · Journal of Clinical Investigation · doi:10.1172/jci67313 · Cited by 2,105
Conserved pan-cancer microenvironment subtypes predict response to immunotherapy
Bagaev, A., Kotlov, N., Nomie, K., Svekolkin, V., Gafurov, A., Isaeva, O., Osokin, N., Kozlov, I., Frenkel, F., Gancharova, O., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.04.014 · Cited by 1,302
Rare-Earth Doping in Nanostructured Inorganic Materials
Zheng, B., Fan, J., Chen, B., Qin, X., Wang, J., Wang, F., Deng, R., & Liu, X. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00644 · Cited by 1,204
Systemic effects of local radiotherapy
Formenti, S. C., & Demaria, S. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70082-8 · Cited by 1,021
Theelen, W. S. M. E., Peulen, H. M. U., Lalezari, F., van der Noort, V., de Vries, J. F., Aerts, J. G. J. V., Dumoulin, D. W., Bahce, I., Niemeijer, A.-L. N., de Langen, A. J., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.1478 · Cited by 1,002
Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype
Barnett, G. C., West, C. M. L., Dunning, A. M., Elliott, R. M., Coles, C. E., Pharoah, P. D. P., & Burnet, N. G. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2587 · Cited by 771
Cited by
Self‐Aggregated Carbon Dots Enable High‐Contrast NIR‐II In Vivo Bioimaging
Guo, S., Liu, W., Lv, C., Li, J., Yang, M., Du, J., Fan, J., & Peng, X. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202523460 · Cited by 15
Self-citationLin, B., Lv, R., Ju, Z., & Ansari, A. A. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217251 · Cited by 12
Du, Q., Wu, G., Xie, A., Wu, D., Hu, W., Lu, Q., Liu, J., Wang, J., Yang, Y., Hu, B., et al. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb00926j · Cited by 7
Li, M., Gao, Z., Wang, N., Sekhar, K. P. C., Hao, J., & Cui, J. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202402954 · Cited by 7
Zeng, B., Ling, K., Yuan, Q., Chen, Z., Zhang, G., Kang, W., Zheng, X., Liao, C., Mai, Y., Huang, Z., et al. (2026) · Theranostics · doi:10.7150/thno.124034 · Cited by 7
“Previous studies have shown that lanthanide-based nanoparticles can reduce required radiation doses by 40–60% [15,16], while still eliciting a robust antitumor immune response [17,18].”
Self-citation
Metadata
- Authors
- Ming, Z., Zhang, Y., Song, L., Chen, M., Lin, L., He, Y., Liu, W., Zhu, Y., Zhang, Y., & Zhang, G.
- Affiliations
- Xiamen University (CN)
- Chinese Academy of Sciences (CN)
- Cancer Center and Department of Breast and Thyroid Surgery Xiang'an Hospital of Xiamen University School of Medicine Xiamen University Xiamen Fujian 361104 China
- Corresponding author
- Zhang, Yun
- Zhang, Guo‐Jun
- Venue
- Advanced Science
- Publisher
- Wiley
- Published
- 2024-05-22
- Volume
- 11
- Issue
- 29
- Pages
- e2309992-e2309992
- ISSN
- 2198-3844 (ISSN-L)
- PMC
- PMC11304243
- OpenAlex
- W4398215405
- Cited by
- 13
- References
- 45
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 1
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Advanced Science (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Fujian Science and Technology Innovation Laboratory for Optoelectronic Information of China (2020ZZ114)
- National Natural Science Foundation of China (62105333, 32171363, 82172009)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
- Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
- Keywords
- triple-negative breast cancer, rare earth nanoparticles, lutetium, neodymium, radioimmunotherapy, radiosensitization, near-infrared imaging, tumor delineation, tumor-infiltrating lymphocytes, immunogenic cell death, lanthanide elements
- MeSH terms
- Animals, Disease Models, Animal, Female, Humans, Metals, Rare Earth, Radioimmunotherapy, Cell Line, Tumor, Mice, Nanoparticles, Triple Negative Breast Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Rare Earth Nanoprobes for Targeted Delineation of Triple Negative Breast Cancer and Enhancement of Radioimmunotherapy. https://app.cochat.ai/papers/10.1002/advs.202309992
- The paper
- Ming, Z., Zhang, Y., Song, L., Chen, M., Lin, L., He, Y., Liu, W., Zhu, Y., Zhang, Y., & Zhang, G. (2024). Rare Earth Nanoprobes for Targeted Delineation of Triple Negative Breast Cancer and Enhancement of Radioimmunotherapy. Advanced Science. https://doi.org/10.1002/advs.202309992
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.